276°
Posted 20 hours ago

UK Medical Eligibility for Contraceptive Use 2016

£7.5£15.00Clearance
ZTS2023's avatar
Shared by
ZTS2023
Joined in 2023
82
63

About this deal

The guidance does not indicate a best method for a woman nor do they take into account efficacy (and this includes drug interactions or malabsorption). The initiation (I) and continuation (C) of a method of contraception can sometimes be distinguished and classified differently (see tables in this Guidelines summary). The duration of use of a method of contraception prior to the new onset of a medical condition may influence decisions regarding continued use. However, there is no set duration and clinical judgement will be required. A condition where the theoretical or proven risks usually outweigh the advantages of using the method. The provision of a method requires expert clinical judgement and/or referral to a specialist contraceptive provider, since use of the method is not usually recommended unless other more appropriate methods are not available or not acceptable Find out more in Which method suits me? Where you can get contraception and emergency contraception progestogen-only injectables (depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN)) and CHC are classed as UKMEC 3.

A woman with current breast cancer would be a 4 for any hormonal method but it would be a 3 if she had breast cancer in the past. This authoritative, ‘go-to’ reference for clinicians provides contraceptives safely to women across the life course. FSRH CEU Response to published study: Maternal use of hormonal contraception and risk of childhood leukemia: a nationwide, populate-based cohort study (September 2018) You can also find out where to get emergency contraception – the "morning after pill" or the IUD (coil). Common questions about contraception The UK Medical Eligibility Criteria (UK MEC 2016) is the authoritative, ‘go-to’ reference for clinicians providing contraceptives safely across the life course.For women with raised BMI with other risk factors for CVD in addition to obesity (e.g. smoking, diabetes, hypertension and dyslipidaemias)

FSRH CEU response to European Medicines Agency recommendations regarding use of ulipristal acetate for management of uterine fibroids (February 2018) Which method works best for you depends on a number of factors, including your age, whether you smoke, your medical and family history, and any medicines you're taking. This guidance provides evidence-based recommendations and good practice points for health professionals on the use of combined hormonal contraceptives (i.e. the combined oral contraceptive pill, transdermal patch and combined vaginal ring) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.When an individual has multiple conditions all scoring UKMEC3 for a method, use of this method may pose an unacceptable risk; clinical judgement should be used in each individual case. It aims to give practical information to everyone who wants to know more about contraception, or who may have a question about the method they use or are thinking about using.

The UK Medical Eligibility Criteria for Contraceptive Use (UKMEC) offers guidance to providers of contraception regarding who can use contraceptive methods safely, including by individuals with certain health conditions (for example hypertension) or characteristics (for example age) to prevent an unintended pregnancyMultiple risk factors for CVD (such as smoking, diabetes, hypertension, obesity and dyslipidaemias) Categories cannot be added together to indicate the safety of using a method. For example, if a woman has two conditions that are each UKMEC2 for use of CHC, these should not be added to make a UKMEC4. However, if multiple UKMEC2 conditions are present that all relate to the same risk, clinical judgement must be used to decide whether the risks of using the method may outweigh the benefits. For example, consider a 34-year-old woman wishing to use combined hormonal contraception (CHC) who has a body mass index (BMI) of 34 kg/m 2 (UKMEC2), is a current smoker (UKMEC2), has a history of superficial venous thrombosis (UKMEC2), and has a first-degree relative who had a venous thromboembolic event at age 50 years (UKMEC2), all potential risk factors for venous thromboembolism (VTE). She might be better advised to consider a different method of contraception that does not increase her risk of VTE Looking at a combined hormonal method a woman with a BMI of 30 would be a UKMEC 2 (generally use) but if she had a BMI of 35 this would be a UKMEC 3 (probably don’t use); a woman who has migraine with aura would be a UKMEC 4 (Do Not Use);

Asda Great Deal

Free UK shipping. 15 day free returns.
Community Updates
*So you can easily identify outgoing links on our site, we've marked them with an "*" symbol. Links on our site are monetised, but this never affects which deals get posted. Find more info in our FAQs and About Us page.
New Comment